InnoGene Co (344860.KQ) Stock Price

InnoGene Co Price

CLOSED
1,317.00KRW+13.00 (+0.99 %)
Market closed

Over the last 6 years InnoGene Co grew revenue by 2.3% annually, reaching 8.94 B KRW. Earnings per share have grown at 2.3% per year over the last 6 years. For InnoGene Co, the net margin of 10.6% is broadly stable versus 11.0% a few years ago. At today's price the dividend yield works out to roughly 6.07%. The payout ratio is around 101% of earnings. The stock trades about 9% above its 52-week low.

InnoGene Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of InnoGene Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how InnoGene Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing InnoGene Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

InnoGene Co Stock Price History
DateInnoGene Co Price
8/10/20261,317.00 KRW
8/7/20261,304.00 KRW
8/6/20261,318.00 KRW
8/5/20261,270.00 KRW
8/4/20261,258.00 KRW
8/3/20261,205.00 KRW
7/31/20261,240.00 KRW
7/30/20261,233.00 KRW
7/29/20261,205.00 KRW
7/28/20261,318.00 KRW
7/27/20261,349.00 KRW
7/24/20261,320.00 KRW
7/23/20261,324.00 KRW
7/22/20261,322.00 KRW
7/21/20261,335.00 KRW
7/20/20261,275.00 KRW
7/16/20261,323.00 KRW
7/15/20261,281.00 KRW
7/14/20261,279.00 KRW
7/13/20261,273.00 KRW
7/10/20261,338.00 KRW
7/9/20261,331.00 KRW
7/8/20261,347.00 KRW
7/7/20261,382.00 KRW
7/6/20261,376.00 KRW
7/3/20261,333.00 KRW
7/2/20261,358.00 KRW
7/1/20261,397.00 KRW
6/30/20261,418.00 KRW
6/29/20261,255.00 KRW
6/26/20261,206.00 KRW
6/25/20261,305.00 KRW
6/24/20261,327.00 KRW
6/23/20261,394.00 KRW
6/22/20261,464.00 KRW
6/19/20261,455.00 KRW
6/18/20261,523.00 KRW
6/17/20261,530.00 KRW
6/16/20261,510.00 KRW
6/15/20261,583.00 KRW
6/12/20261,450.00 KRW
6/11/20261,400.00 KRW
6/10/20261,366.00 KRW
6/9/20261,354.00 KRW
6/8/20261,263.00 KRW
6/5/20261,315.00 KRW
6/4/20261,295.00 KRW
6/2/20261,316.00 KRW
6/1/20261,358.00 KRW
5/29/20261,410.00 KRW
5/28/20261,447.00 KRW
5/27/20261,461.00 KRW
5/26/20261,498.00 KRW
5/22/20261,514.00 KRW
5/21/20261,500.00 KRW
5/20/20261,526.00 KRW
5/19/20261,386.00 KRW
5/18/20261,393.00 KRW
5/15/20261,403.00 KRW
5/14/20261,413.00 KRW
5/13/20261,434.00 KRW
5/12/20261,449.00 KRW
5/11/20261,470.00 KRW
5/8/20261,490.00 KRW
5/7/20261,480.00 KRW
5/6/20261,511.00 KRW
5/4/20261,601.00 KRW
4/30/20261,543.00 KRW
4/29/20261,571.00 KRW
4/28/20261,581.00 KRW
4/27/20261,613.00 KRW
4/24/20261,625.00 KRW
4/23/20261,571.00 KRW
4/22/20261,604.00 KRW
4/21/20261,590.00 KRW
4/20/20261,635.00 KRW
4/17/20261,645.00 KRW
4/16/20261,644.00 KRW
4/15/20261,620.00 KRW
4/14/20261,605.00 KRW
4/13/20261,592.00 KRW
4/10/20261,570.00 KRW
4/9/20261,567.00 KRW
4/8/20261,552.00 KRW
4/7/20261,526.00 KRW
4/6/20261,524.00 KRW
4/3/20261,490.00 KRW
4/2/20261,481.00 KRW
4/1/20261,553.00 KRW
3/31/20261,515.00 KRW
3/30/20261,544.00 KRW
3/27/20261,502.00 KRW
3/26/20261,505.00 KRW
3/25/20261,537.00 KRW
3/24/20261,478.00 KRW
3/23/20261,457.00 KRW
3/20/20261,499.00 KRW
3/19/20261,496.00 KRW
3/18/20261,505.00 KRW
3/17/20261,506.00 KRW
3/16/20261,465.00 KRW
3/13/20261,466.00 KRW
3/12/20261,439.00 KRW
3/11/20261,409.00 KRW
3/10/20261,430.00 KRW
3/9/20261,410.00 KRW
3/6/20261,432.00 KRW
3/5/20261,457.00 KRW
3/4/20261,334.00 KRW
3/3/20261,532.00 KRW
2/27/20261,640.00 KRW
2/26/20261,623.00 KRW
2/25/20261,694.00 KRW
2/24/20261,706.00 KRW
2/23/20261,695.00 KRW
2/20/20261,711.00 KRW
2/19/20261,762.00 KRW
2/13/20261,608.00 KRW
2/12/20261,651.00 KRW
2/11/20261,671.00 KRW
2/10/20261,686.00 KRW
2/9/20261,676.00 KRW
2/6/20261,687.00 KRW
2/5/20261,692.00 KRW
2/4/20261,682.00 KRW
2/3/20261,681.00 KRW
2/2/20261,686.00 KRW
1/30/20261,721.00 KRW
1/29/20261,769.00 KRW
1/28/20261,768.00 KRW
1/27/20261,778.00 KRW
1/26/20261,740.00 KRW
1/23/20261,727.00 KRW
1/22/20261,741.00 KRW
1/21/20261,772.00 KRW
1/20/20261,800.00 KRW
1/19/20261,802.00 KRW
1/16/20261,900.00 KRW
1/15/20261,826.00 KRW
1/14/20261,741.00 KRW
1/13/20261,729.00 KRW
1/12/20261,759.00 KRW
1/9/20261,728.00 KRW
1/8/20261,724.00 KRW
1/7/20261,780.00 KRW
1/6/20261,814.00 KRW
1/5/20261,879.00 KRW
1/2/20261,909.00 KRW
12/30/20251,864.00 KRW
12/29/20251,932.00 KRW
12/26/20252,075.00 KRW
12/24/20251,881.00 KRW
12/23/20251,949.00 KRW
12/22/20252,040.00 KRW
12/19/20252,110.00 KRW
12/18/20252,160.00 KRW
12/17/20252,255.00 KRW
12/16/20251,736.00 KRW
12/15/20251,752.00 KRW
12/12/20251,686.00 KRW
12/11/20251,719.00 KRW
12/10/20251,719.00 KRW
12/9/20251,743.00 KRW
12/8/20251,721.00 KRW
12/5/20251,673.00 KRW
12/4/20251,630.00 KRW
12/3/20251,656.00 KRW
12/2/20251,646.00 KRW
12/1/20251,645.00 KRW
11/28/20251,611.00 KRW
11/27/20251,641.00 KRW
11/26/20251,604.00 KRW
11/25/20251,567.00 KRW
11/24/20251,592.00 KRW
11/21/20251,617.00 KRW
11/20/20251,629.00 KRW
11/19/20251,601.00 KRW
11/18/20251,635.00 KRW
11/17/20251,650.00 KRW
11/14/20251,630.00 KRW
11/13/20251,626.00 KRW
11/12/20251,610.00 KRW
11/11/20251,647.00 KRW
11/10/20251,670.00 KRW
11/7/20251,670.00 KRW
11/6/20251,662.00 KRW
11/5/20251,680.00 KRW
11/4/20251,649.00 KRW
11/3/20251,624.00 KRW
10/31/20251,610.00 KRW
10/30/20251,628.00 KRW
10/29/20251,626.00 KRW
10/28/20251,626.00 KRW
10/27/20251,611.00 KRW
10/24/20251,609.00 KRW
10/23/20251,610.00 KRW
10/22/20251,625.00 KRW
10/21/20251,620.00 KRW
10/20/20251,626.00 KRW
10/17/20251,610.00 KRW
10/16/20251,716.00 KRW
10/15/20251,640.00 KRW
10/14/20251,690.00 KRW
10/13/20251,700.00 KRW
10/10/20251,738.00 KRW
10/2/20251,760.00 KRW
10/1/20251,717.00 KRW
9/30/20251,774.00 KRW
9/29/20251,722.00 KRW
9/26/20251,732.00 KRW
9/25/20251,747.00 KRW
9/24/20251,747.00 KRW
9/23/20251,763.00 KRW
9/22/20251,748.00 KRW
9/18/20251,773.00 KRW
9/17/20251,757.00 KRW
9/16/20251,761.00 KRW
9/15/20251,755.00 KRW
9/12/20251,800.00 KRW
9/11/20251,814.00 KRW
9/10/20251,793.00 KRW
9/9/20251,777.00 KRW
9/8/20251,797.00 KRW
9/5/20251,780.00 KRW
9/4/20251,766.00 KRW
9/3/20251,755.00 KRW
9/2/20251,730.00 KRW
9/1/20251,733.00 KRW
8/29/20251,742.00 KRW
8/28/20251,827.00 KRW
8/27/20251,788.00 KRW
8/26/20251,806.00 KRW
8/25/20251,816.00 KRW
8/22/20251,800.00 KRW
8/21/20251,795.00 KRW
8/20/20251,792.00 KRW
8/19/20251,811.00 KRW
8/18/20251,815.00 KRW
8/14/20251,849.00 KRW
8/13/20251,833.00 KRW
8/12/20251,832.00 KRW
8/11/20251,861.00 KRW
Access this data via the Eulerpool API
Get Free API Key

InnoGene Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
7.81 B KRW
42.40 M KRW
68.90 M KRW
Jan 1, 2019
5.64 B KRW
-253.80 M KRW
-412.30 M KRW
Jan 1, 2020
7.18 B KRW
1.13 B KRW
790.10 M KRW
Jan 1, 2021
9.39 B KRW
2.40 B KRW
2.26 B KRW
Jan 1, 2022
9.14 B KRW
1.49 B KRW
1.34 B KRW
Jan 1, 2023
10.10 B KRW
1.23 B KRW
1.40 B KRW
Jan 1, 2024
8.94 B KRW
630.49 M KRW
945.16 M KRW

InnoGene Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 8:34 PM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
2018201920202021202220232024
7.815.647.189.399.1410.108.94
–-27.7227.2630.69-2.6210.53-11.45
68.7273.0874.7478.0474.2672.5674.17
5.374.125.377.326.797.336.63
0.04-0.251.132.401.491.230.63
0.54-4.4815.6725.5516.2712.147.04
0.07-0.410.792.261.341.400.95
–-705.88-291.75185.70-40.674.26-32.31
–––––30.0080.00
––––––166.67
1.001.009.309.309.3011.6311.96
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales InnoGene Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue InnoGene Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare InnoGene Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares InnoGene Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against InnoGene Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

InnoGene Co stock margins

The InnoGene Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of InnoGene Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for InnoGene Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
68.72 %
0.54 %
0.88 %
Jan 1, 2019
73.09 %
-4.50 %
-7.31 %
Jan 1, 2020
74.73 %
15.67 %
11.00 %
Jan 1, 2021
78.04 %
25.56 %
24.06 %
Jan 1, 2022
74.26 %
16.28 %
14.65 %
Jan 1, 2023
72.56 %
12.14 %
13.82 %
Jan 1, 2024
74.18 %
7.05 %
10.57 %

InnoGene Co Stock Revenue, EBIT, Earnings per Share

The InnoGene Co earnings per share therefore indicates how much revenue InnoGene Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
7,807.80 KRW
42.40 KRW
68.90 KRW
Jan 1, 2019
5,643.70 KRW
-253.80 KRW
-412.30 KRW
Jan 1, 2020
772.19 KRW
120.98 KRW
84.96 KRW
Jan 1, 2021
1,009.14 KRW
257.90 KRW
242.76 KRW
Jan 1, 2022
982.73 KRW
159.96 KRW
144.01 KRW
Jan 1, 2023
868.24 KRW
105.41 KRW
120.01 KRW
Jan 1, 2024
748.00 KRW
52.73 KRW
79.04 KRW

InnoGene Co business model & stock analysis

InnoGene Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

InnoGene Co historical P/E ratio, EBIT multiple, and P/S ratio

InnoGene Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

InnoGene Co shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
1.00 M Stocks
Jan 1, 2019
1.00 M Stocks
Jan 1, 2020
9.30 M Stocks
Jan 1, 2021
9.30 M Stocks
Jan 1, 2022
9.30 M Stocks
Jan 1, 2023
11.63 M Stocks
Jan 1, 2024
11.96 M Stocks

InnoGene Co Dividend History

2 years of dividend payments

YearAnnual DividendYoY ChangePayments
202480.00KRW↑ 166.7%1×
202330.00KRW—1×

InnoGene Co dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
63.11 %
Jan 1, 2019
63.11 %
Jan 1, 2020
63.11 %
Jan 1, 2021
63.11 %
Jan 1, 2022
63.11 %
Jan 1, 2023
25.00 %
Jan 1, 2024
101.22 %
Price targets and forecasts for InnoGene Co are not yet available.

InnoGene Co shareholder structure

% Name
34.70480%
Lee (Gwang Hun)
Lee (Gwang Hun)
7.34236%
Soelistyo (Antonius Rachmat)
Soelistyo (Antonius Rachmat)
7.27787%
Gwon (Deuk Mun)
Gwon (Deuk Mun)
1.90667%
Yu (Mi Ra)
Yu (Mi Ra)
0.00961%
Inojin Co., Ltd. Employees
Inojin Co., Ltd. Employees

InnoGene Co Executives and Management Board

1 members · avg. age 55 · 0 % women

GL

Mr. Gong Myeong Lee (55)

Non-Executive Independent Director

–

Frequently asked questions about InnoGene Co

Converted at the current exchange rate, the InnoGene Co share trades at 0.81 EUR (1,317.00 KRW).

No history available for InnoGene Co.

The revenue cannot currently be calculated for InnoGene Co.

The profit cannot currently be calculated for InnoGene Co.

The P/E ratio cannot be calculated for InnoGene Co at the moment.

The P/S cannot be calculated for InnoGene Co currently.

The Eulerpool Quality Score for InnoGene Co is 1/10.

The ISIN of InnoGene Co is KR7344860002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of InnoGene Co is 344860.KQ. The ticker symbol is used to trade InnoGene Co shares on the stock exchange.

Over the past 12 months, InnoGene Co paid a dividend of 80.00 KRW . This corresponds to a dividend yield of about 6.07 %. For the coming 12 months, InnoGene Co is expected to pay a dividend of 110.00 KRW.

The current dividend yield of InnoGene Co is 6.07 %.

InnoGene Co paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 110.00 KRW are expected. This corresponds to a dividend yield of 8.35 %.

InnoGene Co is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of InnoGene Co from amounting to 80 KRW, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of InnoGene Co are distributed in KRW.

All fundamentals and in-depth analysis of InnoGene Co

Our stock analysis for InnoGene Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InnoGene Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

InnoGene Co Stock
InnoGene Co Revenue→
InnoGene Co Stock
InnoGene Co Net Income→
InnoGene Co Stock
InnoGene Co P/E→
InnoGene Co Stock
InnoGene Co P/S→
InnoGene Co Stock
InnoGene Co EBIT→
InnoGene Co Stock
InnoGene Co Dividend→
InnoGene Co Stock
InnoGene Co Directors Dealings→
InnoGene Co Stock
InnoGene Co Stocks→
InnoGene Co Stock
InnoGene Co Market capitalization→
InnoGene Co Stock
InnoGene Co Debt→
InnoGene Co Stock
InnoGene Co Liabilities→
InnoGene Co Stock
InnoGene Co Equity→
InnoGene Co Stock
InnoGene Co AAQS→
InnoGene Co Stock
InnoGene Co Employees→
InnoGene Co Stock
InnoGene Co ROE→
InnoGene Co Stock
InnoGene Co ROA→
InnoGene Co Stock
InnoGene Co ROCE→
InnoGene Co Stock
InnoGene Co News→
InnoGene Co Stock
InnoGene Co Analyst Price Targets→

Non-cyclical consumption Stocks

Innovation Beverage GroupInner Mongolia Yili Industrial Group CoInnovation New Material Technology CoIngredionInnovative Food HoldingsIngles MarketsInsanInghams GroupIntegrated BiopharmaIndustri Jamu dan Farmasi Sido Muncul Tbk PTInter Pharma PCLIndong Tea CompanyAll Stocks A–Z →